Cue Biopharma (CUE) Short Interest Ratio & Short Volume $1.09 +0.01 (+0.93%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cue Biopharma Short Interest DataCue Biopharma (CUE) has a short interest of 1.78 million shares. This marks a -8.72% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.6, indicating that it would take 2.6 days of the average trading volume of 739,066 shares to cover all short positions.Current Short Interest1,780,000 sharesPrevious Short Interest1,950,000 sharesChange Vs. Previous Month-8.72%Dollar Volume Sold Short$2.87 millionShort Interest Ratio2.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares48,640,000 sharesPercentage of Shares Shorted3.66%Today's Trading Volume409,315 sharesAverage Trading Volume739,066 sharesToday's Volume Vs. Average55% Short Selling Cue Biopharma? Sign up to receive the latest short interest report for Cue Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCUE Short Interest Over TimeCUE Days to Cover Over TimeCUE Percentage of Float Shorted Over Time Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Cue Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20241,780,000 shares $2.87 million -8.7%N/A2.6 $1.61 10/15/20241,950,000 shares $2.18 million -48.7%N/A2.9 $1.12 9/30/20243,800,000 shares $2.88 million +6.7%N/A6.6 $0.76 9/15/20243,560,000 shares $2.10 million +3.8%N/A8.2 $0.59 8/31/20243,430,000 shares $2.48 million -6.3%N/A7.7 $0.72 8/15/20243,660,000 shares $2.17 million -9.2%N/A8.1 $0.59 Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/20244,030,000 shares $3.37 million +8.3%N/A8.9 $0.84 7/15/20243,720,000 shares $3.46 million -21.5%N/A9.7 $0.93 6/30/20244,740,000 shares $5.88 million +5.6%N/A12.3 $1.24 6/15/20244,490,000 shares $6.11 million +3.2%N/A15.9 $1.36 5/31/20244,350,000 shares $7.09 million -5.2%N/A15.5 $1.63 5/15/20244,590,000 shares $7.53 million -7.5%N/A15.5 $1.64 4/30/20244,960,000 shares $9.42 million +3.8%N/A17.2 $1.90 4/15/20244,780,000 shares $7.62 million +13.8%N/A18.7 $1.60 3/31/20244,200,000 shares $7.94 million +1.9%N/A15.8 $1.89 3/15/20244,120,000 shares $8.53 million +3.8%N/A14.7 $2.07 2/29/20243,970,000 shares $8.24 million +4.2%N/A12.7 $2.08 2/15/20243,810,000 shares $8.95 million +5.8%N/A10.8 $2.35 1/31/20243,600,000 shares $9.50 million -1.4%N/A10.6 $2.64 1/15/20243,650,000 shares $10.91 million +6.7%N/A10.1 $2.99 12/31/20233,420,000 shares $9.03 million +5.2%N/A9.4 $2.64 12/15/20233,250,000 shares $9.20 million +8.3%N/A9.5 $2.83 11/30/20233,000,000 shares $7.50 million -1.0%N/A10 $2.50 11/15/20233,030,000 shares $7.21 million -2.6%N/A11.8 $2.38 10/31/20233,110,000 shares $6.53 million +19.6%N/A10.2 $2.10 10/15/20232,600,000 shares $5.33 million +2.4%N/A8.2 $2.05 9/30/20232,540,000 shares $5.84 million +2.8%N/A6.7 $2.30 9/15/20232,470,000 shares $6.32 million +1.2%N/A5.2 $2.56 8/31/20232,440,000 shares $6.61 million -20.3%N/A5 $2.71 8/15/20233,060,000 shares $8.60 million -5.9%N/A6.2 $2.81 7/31/20233,250,000 shares $12.42 million +30.0%N/A7.1 $3.82 7/15/20232,500,000 shares $11.13 million +28.2%N/A5.5 $4.45 6/30/20231,950,000 shares $7.12 million +142.2%N/A5.4 $3.65 6/15/2023805,200 shares $3.12 million +10.1%N/A2.5 $3.87 5/31/2023731,600 shares $2.93 million +36.2%N/A3 $4.00 5/15/2023537,100 shares $2.39 million +1.0%N/A2.4 $4.45 4/30/2023531,900 shares $2.30 million -21.6%N/A2.8 $4.33 4/15/2023678,200 shares $2.36 million -10.5%N/A4.8 $3.48 3/31/2023757,900 shares $2.71 million +35.4%N/A5.5 $3.57 3/15/2023559,600 shares $1.75 million +21.8%N/A4.4 $3.12I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/28/2023459,500 shares $1.29 million +4.9%N/A4.3 $2.80 2/15/2023438,000 shares $1.47 million -12.7%N/A3.9 $3.35 1/31/2023501,900 shares $1.72 million -22.1%N/A3.9 $3.42 1/15/2023644,500 shares $2.24 million +8.8%N/A5 $3.48 12/30/2022592,200 shares $1.69 million -17.4%N/A4.4 $2.85 12/15/2022717,000 shares $2.03 million -5.7%N/A4.4 $2.83 11/30/2022759,900 shares $2.93 million -12.9%N/A4.8 $3.86 11/15/2022872,100 shares $3.30 million -29.7%N/A5.4 $3.78 10/31/20221,240,000 shares $3.30 million -10.8%N/A7.6 $2.66 10/15/20221,390,000 shares $3.57 million -6.1%N/A8.2 $2.57 9/30/20221,480,000 shares $3.30 million -12.4%N/A8.2 $2.23 9/15/20221,690,000 shares $5.53 million -12.9%N/A6 $3.27 8/31/20221,940,000 shares $5.70 million No ChangeN/A6.1 $2.94 8/15/20221,940,000 shares $6.48 million -11.0%N/A5.5 $3.34 7/31/20222,180,000 shares $5.93 million -0.5%N/A5.5 $2.72 7/15/20222,190,000 shares $5.76 million -3.5%N/A5.2 $2.63 6/30/20222,270,000 shares $5.65 million -36.6%N/A4.8 $2.49 6/15/20223,580,000 shares $11.06 million -8.7%11.6%7.2 $3.09 5/31/20223,920,000 shares $15.17 million -4.6%12.7%8.3 $3.87 5/15/20224,110,000 shares $14.84 million No Change13.2%8.5 $3.61 4/30/20224,110,000 shares $16.28 million +15.1%13.2%8.5 $3.96 4/15/20223,570,000 shares $16.21 million +6.6%11.5%6.5 $4.54 3/31/20223,350,000 shares $16.35 million -12.3%10.8%6.3 $4.88 3/15/20223,820,000 shares $16.85 million +8.5%N/A8 $4.41 2/28/20223,520,000 shares $20.42 million +1.4%11.5%8.3 $5.80 2/15/20223,470,000 shares $24.64 million +29.0%11.3%8.2 $7.10 1/31/20222,690,000 shares $19.88 million +18.0%8.8%6.5 $7.39 1/15/20222,280,000 shares $22.69 million +11.8%7.4%6.9 $9.95 12/31/20212,040,000 shares $23.07 million +10.9%6.7%6.4 $11.31 12/15/20211,840,000 shares $20.68 million +10.8%6.0%5.8 $11.24 11/30/20211,660,000 shares $20.35 million -8.8%5.4%5.3 $12.26 11/15/20211,820,000 shares $32.49 million -9.9%5.9%6.1 $17.85 10/29/20212,020,000 shares $24.66 million +3.1%6.8%7.8 $12.21 10/15/20211,960,000 shares $24.70 million -2.5%6.6%7.8 $12.60 9/30/20212,010,000 shares $29.29 million -15.6%6.8%8.6 $14.57 9/15/20212,380,000 shares $28.82 million -4.8%8.0%10.6 $12.11 8/31/20212,500,000 shares $29.98 million -2.0%8.4%12.7 $11.99 8/13/20212,550,000 shares $28.33 million -3.4%8.6%12.7 $11.11 7/30/20212,640,000 shares $27.51 million -2.2%8.9%6.2 $10.42 7/15/20212,700,000 shares $27.51 million -0.4%9.1%6.2 $10.19 6/30/20212,710,000 shares $31.57 million +1.5%9.1%6 $11.65 6/15/20212,670,000 shares $35.22 million -6.3%9.0%5.9 $13.19 5/28/20212,850,000 shares $40.87 million -5.3%9.6%6.1 $14.34 5/14/20213,010,000 shares $38.98 million +16.2%N/A6 $12.95 4/30/20212,590,000 shares $31.11 million -10.4%N/A5.3 $12.01 4/15/20212,890,000 shares $36.04 million -8.0%N/A9.3 $12.47 3/31/20213,140,000 shares $36.11 million +11.0%N/A10.1 $11.50 3/15/20212,830,000 shares $44.57 million +1.8%N/A8.5 $15.75 2/26/20212,780,000 shares $36.78 million +0.7%N/A8.8 $13.23 2/12/20212,760,000 shares $43.33 million -5.8%N/A9.3 $15.70I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 1/29/20212,930,000 shares $39.82 million +1.4%N/A10 $13.59 1/15/20212,890,000 shares $36.79 million +4.7%N/A9.8 $12.73 12/31/20202,760,000 shares $35.55 million +3.4%N/A10.4 $12.88 12/15/20202,670,000 shares $36.37 million -6.6%N/A10.4 $13.62 11/30/20202,860,000 shares $39.30 million -0.7%N/A10.8 $13.74 11/15/20202,880,000 shares $34.30 million +5.5%N/A10.3 $11.91 10/30/20202,730,000 shares $33.03 million +11.0%N/A10.3 $12.10 10/15/20202,460,000 shares $38.40 million -5.8%N/A9.3 $15.61 9/30/20202,610,000 shares $39.28 million +12.5%N/A9.9 $15.05 9/15/20202,320,000 shares $41.78 million +7.4%N/A7.5 $18.01 8/31/20202,160,000 shares $38.60 million -0.9%N/A6.6 $17.87 8/14/20202,180,000 shares $44.36 million +1.4%N/A7 $20.35 7/31/20202,150,000 shares $40.66 million +1.4%N/A6.3 $18.91 7/15/20202,120,000 shares $45.24 million +21.8%N/A5.9 $21.34 6/30/20201,740,000 shares $40.65 million +149.4%N/A4.7 $23.36 6/15/2020697,700 shares $19.19 million +12.2%N/A2 $27.50 5/29/2020622,000 shares $17.22 million -36.9%N/A1.9 $27.68 5/15/2020985,400 shares $25.25 million +12.1%N/A3.2 $25.62 4/30/2020878,900 shares $22.56 million -15.5%N/A3 $25.67 4/15/20201,040,000 shares $20.50 million -32.0%N/A3.9 $19.71 3/31/20201,530,000 shares $37.12 million +29.4%N/A6.5 $24.26 3/13/20201,182,000 shares $21.24 million +7.5%6.2%4.8 $17.97 2/28/20201,100,000 shares $13.38 million +4.8%5.8%4.3 $12.16 2/14/20201,050,000 shares $18.18 million -1.9%5.5%4.1 $17.31 1/31/20201,070,000 shares $20.26 million +9.5%6.2%4.1 $18.93 1/15/2020976,800 shares $19.54 million +2.8%5.6%4.2 $20.00 12/31/2019950,700 shares $14.46 million +3.9%5.5%4.5 $15.21 CUE Short Interest - Frequently Asked Questions What is Cue Biopharma's current short interest? Short interest is the volume of Cue Biopharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 1,780,000 shares of CUE short. Learn More on Cue Biopharma's current short interest. What is a good short interest ratio for Cue Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CUE shares currently have a short interest ratio of 3.0. Learn More on Cue Biopharma's short interest ratio. Is Cue Biopharma's short interest increasing or decreasing? Cue Biopharma saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 1,780,000 shares, a decline of 8.7% from the previous total of 1,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cue Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cue Biopharma: Silence Therapeutics plc (1.18%), Inhibrx, Inc. (9.70%), Zura Bio Limited (4.14%), Editas Medicine, Inc. (20.88%), Solid Biosciences Inc. (4.40%), XBiotech Inc. (4.29%), Corbus Pharmaceuticals Holdings, Inc. (20.17%), Amarin Co. plc (4.37%), Enanta Pharmaceuticals, Inc. (17.46%), ADC Therapeutics SA (3.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Cue Biopharma stock? Short selling CUE is an investing strategy that aims to generate trading profit from Cue Biopharma as its price is falling. CUE shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cue Biopharma? A short squeeze for Cue Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUE, which in turn drives the price of the stock up even further. How often is Cue Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUE, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies SLN Short Squeeze INBX Short Squeeze ZURA Short Squeeze EDIT Short Squeeze SLDB Short Squeeze XBIT Short Squeeze CRBP Short Squeeze AMRN Short Squeeze ENTA Short Squeeze ADCT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CUE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CUE Stock Alerts